Heidelberg

EQS-News: SNP: Strong customer and partner confidence leads to improved growth outlook for the full year 2023

Retrieved on: 
Tuesday, December 12, 2023
EBIT, RISE, Heidelberg, Data management, Ecosystem, SNP, SAP

CEO Jens Amail of SNP Schneider-Neureither & Partner SE comments the development of the company: "We are very pleased with the progress we have made.

Key Points: 
  • CEO Jens Amail of SNP Schneider-Neureither & Partner SE comments the development of the company: "We are very pleased with the progress we have made.
  • Despite strong negative exchange rate effects, we will significantly improve our operational results compared to the previous year and accordingly fulfil our forecast.
  • We are capitalizing on positive market momentum, driven in particular by migrations to SAP S4/HANA and RISE.
  • The positive response from customers and partners to our CrystalBridge software and Bluefield Methodology globally is a testament to our leadership in the market for complex selective data migrations.”

EQS-News: SNP: New Management System Effective Following Registration in the Commercial Register

Retrieved on: 
Tuesday, November 7, 2023
CFO, Environment, Heidelberg, SAP, SNP, Software, Data management, Security (finance), Management

Heidelberg, October 30, 2023 – The dualistic management system, as resolved at the extraordinary general meeting of SNP Schneider-Neureither & Partner SE, a globally leading provider of software for digital transformations, automated data migrations, and data management in the SAP environment, has become effective with the registration of the articles of association change in the commercial register.

Key Points: 
  • Heidelberg, October 30, 2023 – The dualistic management system, as resolved at the extraordinary general meeting of SNP Schneider-Neureither & Partner SE, a globally leading provider of software for digital transformations, automated data migrations, and data management in the SAP environment, has become effective with the registration of the articles of association change in the commercial register.
  • That means the newly elected three-member supervisory board approved by the general meeting is now officially in office.
  • The supervisory board conists of Dr. Karl Benedikt Biesinger as Chairman, Prof. Dr. Thorsten Grenz as Deputy Chairman, and Peter Maier.
  • Dr. Karl Benedikt Biesinger, Chairman of the SNP supervisory board, commented: "With the registration of the articles of association change in the commercial register, all formal steps are completed for introducing the dualistic management system .

EQS-News: Ongoing feasibility study for battery plant for CERENERGY® sees significantly higher annual production capacity

Retrieved on: 
Tuesday, November 7, 2023
Fraunhofer Institute for Solar Energy Systems, FRA, Heidelberg, Nickel, Cobalt, Lithium, Vehicle registration plates of Nepal, Hospital, Graphite, Heat, Ceramic, Investment, Chemistry, Fraunhofer Society, Renewable energy, Electric battery, Fraunhofer

Through technical optimization, the annual production capacity could be increased from previously 100 MWh for CERENERGY plant in Schwarze Pumpe to 120MWh.

Key Points: 
  • Through technical optimization, the annual production capacity could be increased from previously 100 MWh for CERENERGY plant in Schwarze Pumpe to 120MWh.
  • Heidelberg (02.11.2023): Altech Advanced Materials AG (FRA: AMA1) will significantly expand its production capacity at the CERENERGY® solid-state sodium chloride battery production facility in Schwarze Pumpe, Saxony, Germany, to at least 120 MWh annually.
  • Altech is currently preparing a comprehensive feasibility study for the realization of the production plant.
  • Through optimized design, we have succeeded in significantly expanding production capacity without incurring additional investment costs for Altech.

FuelCell Energy Electrolyzer to be used in UK Hydrogen and Nuclear Study

Retrieved on: 
Wednesday, October 18, 2023
Hydrogen, Heidelberg, National Nuclear Laboratory, EDF Energy, Business development, Energy, FuelCell Energy, Electricity, Nuclear power plant, Nuclear power, B cell, PEM, EDF, Electrolysis, SOEC, North West England, Overalls, Oil, Lithium, Heysham

DANBURY, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) has been contracted by EDF Energy for a project exploring the viability of using hydrogen to decarbonize asphalt production.

Key Points: 
  • DANBURY, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) has been contracted by EDF Energy for a project exploring the viability of using hydrogen to decarbonize asphalt production.
  • The Bay Hydrogen Hub consortium, which is made up of EDF , Heidelberg UK , the National Nuclear Laboratory , and Vulcan Burners , proposes combining the use of FuelCell Energy’s 1-Megawatt Solid Oxide Electrolyzer Cell (SOEC) with nuclear generated heat and electricity to produce hydrogen in bulk at a lower cost than other hydrogen electrolysis technologies.
  • FuelCell Energy President and CEO Jason Few commented, “ Solid oxide electrolysis is ideal for producing hydrogen from nuclear power sources.
  • The funding is from the UK government’s £1 billion ($1.2b) Net Zero Innovation Portfolio (NZIP), which provides funding for low-carbon technologies and systems.

EQS-News: SNP stays on its growth path after best Q3 results ever

Retrieved on: 
Tuesday, October 17, 2023
Software, Trust, Humble Bundle, SAP, Ecosystem, Heidelberg, SNP, Data management, EBIT, Video game

The Company achieved an increase in order entry of around 50% to approximately € 60 million in the third quarter of fiscal year 2023 (Q3 2022: € 40.1 million).

Key Points: 
  • The Company achieved an increase in order entry of around 50% to approximately € 60 million in the third quarter of fiscal year 2023 (Q3 2022: € 40.1 million).
  • Revenue grew by around 29 % to approximately € 53.5 million in the same period (Q3 2022: € 41.6 million); the operating earnings (EBIT) improved significantly to approximately € 4.5 million (Q3 2022: € 0.1 million).
  • This led to an over-proportional growth of our software segment in an overall strong quarter.
  • We are thrilled and humbled, that 16 out of the top 20 SAP System Integrators have decided to partner with SNP.

Heidelberg Engineering Announces FDA Clearance for All-in-One ANTERION Platform

Retrieved on: 
Friday, October 13, 2023
Apps, Applications, Technology, Medical Devices, FDA, Health Technology, Software, Biotechnology, Hardware, Health, Optical, Diagnosis, Multimedia, Lumia imaging apps, Acquisition, Corneal topography, Aqueous humour, OD, OCT, Clinical trial, Cataract, Heidelberg, IOL, Tomography, Cornea, Medical device, Medical imaging, Telescopic sight

Heidelberg Engineering , a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of its innovative all-in-one ANTERION® platform , designed to transform anterior segment diagnostics and streamline practice workflow.

Key Points: 
  • Heidelberg Engineering , a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of its innovative all-in-one ANTERION® platform , designed to transform anterior segment diagnostics and streamline practice workflow.
  • View the full release here: https://www.businesswire.com/news/home/20231013216160/en/
    “Building upon our previous CE-marking, we are thrilled that the ANTERION platform is now available to eye care providers across the U.S.,” said Arianna Schoess Vargas, Managing Director of Heidelberg Engineering GmbH.
  • Central to the ANTERION platform is the Imaging App, which was FDA cleared in November 2021.
  • For more information about ANTERION, visit our website or contact us directly.

EQS-News: SNP: General Meeting passes resolution to introduce dualistic management system – new Supervisory Board elected

Retrieved on: 
Thursday, September 28, 2023
Heidelberg, Data management, Audit committee, Islamabad Wildlife Management Board, Supervisory board, Trust, Environment, SAP, SNP, Supervision, Software, Property management

The controlling function will be assumed by the new three-member Supervisory Board, which consists of Dr. Karl Benedikt Biesinger, Prof. Dr. Thorsten Grenz and Peter Maier.

Key Points: 
  • The controlling function will be assumed by the new three-member Supervisory Board, which consists of Dr. Karl Benedikt Biesinger, Prof. Dr. Thorsten Grenz and Peter Maier.
  • At its constituent meeting, the Supervisory Board elected Dr. Biesinger as Chairman and Prof. Dr. Grenz as Deputy Chairman.
  • The changes we have made ensure a clear management model that is customary in the industry, with the two bodies of the Management Board and Supervisory Board that are customary for listed companies in Germany.
  • At its first meeting, the Supervisory Board also established an Audit Committee.

European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies

Retrieved on: 
Tuesday, September 5, 2023
Neuropsychology, Therapy, Frontiers, MD, EWA, Medicine, BWA, Quality of life, Immunomodulation, Rehabilitation, Research, Heidelberg University Faculty of Law, Language, International trade, Down syndrome, MRI, DSM-IV codes, Cell biology, Heidelberg University, Economic development, Spectrum, Heidelberg, Brain and Behavior, Growth, CPD, Medical device, Pharmaceutical industry, Neuroscience, DS, Neuroanatomy, Brain, Behavior, Anatomy

The studies promise a paradigm shift in developing personalized rehabilitation strategies and care programs.

Key Points: 
  • The studies promise a paradigm shift in developing personalized rehabilitation strategies and care programs.
  • "Individualized assessment of neuroanatomical landmarks and cognitive skills is paramount for developing effective intervention strategies," commented Heidelberg University's Head of Neuroanatomy, Prof. Dr. Thomas Skutella.
  • Established in 1386, Heidelberg University is Germany's oldest university and a renowned research powerhouse in Stem Cell Research & Immunology in Europe.
  • With 56 Nobel Laureates associated with the institution, Heidelberg University boasts an illustrious history.

European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies

Retrieved on: 
Tuesday, September 5, 2023
Neuropsychology, Therapy, Frontiers, MD, EWA, Medicine, BWA, Quality of life, Immunomodulation, Rehabilitation, Research, Multimedia, Heidelberg University Faculty of Law, Language, International trade, Down syndrome, MRI, DSM-IV codes, Cell biology, Heidelberg University, Economic development, Spectrum, Heidelberg, Brain and Behavior, Growth, CPD, Medical device, Pharmaceutical industry, Neuroscience, DS, Neuroanatomy, Brain, Behavior, Anatomy

The studies promise a paradigm shift in developing personalized rehabilitation strategies and care programs.

Key Points: 
  • The studies promise a paradigm shift in developing personalized rehabilitation strategies and care programs.
  • "Individualized assessment of neuroanatomical landmarks and cognitive skills is paramount for developing effective intervention strategies," commented Heidelberg University's Head of Neuroanatomy, Prof. Dr. Thomas Skutella.
  • Established in 1386, Heidelberg University is Germany's oldest university and a renowned research powerhouse in Stem Cell Research & Immunology in Europe.
  • With 56 Nobel Laureates associated with the institution, Heidelberg University boasts an illustrious history.

AGC Biologics Completes Expansion at Milan Cell and Gene Therapy Development and Manufacturing Site

Retrieved on: 
Wednesday, August 9, 2023
Biotechnology, Pharmaceutical, Health, Messenger RNA, GMP, DNA, Plasmid, Gene, Center for Cell and Gene Therapy, Viral vector, Gene-centered view of evolution, AGC, Messenger, CDMO, CGMP, Cell, Heidelberg, Vaccine

AGC Biologics , a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the company completed the expansion of its manufacturing space at its Milan Cell & Gene Center of Excellence production site.

Key Points: 
  • AGC Biologics , a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the company completed the expansion of its manufacturing space at its Milan Cell & Gene Center of Excellence production site.
  • “This is another important milestone for our site and for the AGC Biologics global Cell and Gene network as we prepare to serve more developers,” said Luca Alberici, General Manager, AGC Biologics Milan.
  • AGC Biologics operates two cell and gene facilities within its global network, one in Milan and one in Longmont, Col, USA.
  • At each site AGC Biologics offers end-to-end global viral vector and cell therapy development, manufacturing, and quality/regulatory services, using the latest technology platforms and scientific methods.